A meta-analysis of case-control studies of the association of migraine and patent foramen ovale

A meta-analysis of case-control studies of the association of migraine and patent foramen ovale
复制标题

DOI:
10.1016/j.jjcc.2015.09.016
复制
发表时间:
2016-05-01
影响因子:
2.5
通讯作者:
Umemoto, Takuya
Umemoto, Takuya
中科院分区:
医学3区
文献类型:
--
作者:
Takagi, Hisato;Umemoto, Takuya

文献摘要

被引文献

相似文献

目的:为了建立定量证据,我们对评估偏头痛与卵圆孔未闭(PFO)之间关系的病例对照研究进行了首次荟萃分析。方法:使用PubMed和奥维德检索MEDLINE和EMBASE,检索时间截止2015年4月。符合条件的研究是病例对照研究报告PFO(或偏头痛)患病率偏头痛患者与无偏头痛科目(或PFO患者与无PFO科目)。结果:395个潜在的相关文章初步筛选,21个合格的研究,共招募5572名参与者被确定和列入。合并分析显示,有先兆偏头痛患病率为3.36倍[比值比(OR),3.36; 95%置信区间(CI),2.04-5.55; p < 0.00001],有/无先兆偏头痛患病率为2.46倍,具有统计学意义(OR,2.46; 95% CI,1.55-3.91; p = 0.0001)但无统计学意义的1.30倍无先兆偏头痛患病率(OR,1.30; 95%CI,0.85-1.99; p = 0.22)。PFO与3.4倍有先兆偏头痛和2.5倍有/无先兆偏头痛患病率相关,但与无先兆偏头痛患病率无关。(C)2015年由Elsevier Ltd代表日本心脏病学院发表。
Objectives: To establish quantitative evidence, we performed the first meta-analysis of case-control studies assessing the relationship between migraine and patent foramen ovale (PFO).Methods: MEDLINE and EMBASE were searched through April 2015 using PubMed and OVID. Eligible studies were case-control studies reporting PFO (or migraine) prevalence in migraine patients versus no migraine subjects (or PFO patients versus no-PFO subjects).Results: Of 395 potentially relevant articles screened initially, 21 eligible studies enrolling a total of 5572 participants were identified and included. Pooled analyses demonstrated statistically significant 3.36-fold migraine-with-aura [odds ratio (OR), 3.36; 95% confidence interval (CI), 2.04-5.55; p < 0.00001] and 2.46-fold migraine-with/without-aura prevalence (OR, 2.46; 95% CI, 1.55-3.91; p = 0.0001) but statistically non-significant 1.30-fold migraine-without-aura prevalence (OR, 1.30; 95% CI, 0.85-1.99; p = 0.22) in PFO patients relative to no-PFO subjects.Conclusions: PFO is associated with 3.4-fold migraine-with-aura and 2.5-fold migraine-with/without-aura prevalence but unassociated with migraine-without-aura prevalence. (C) 2015 Published by Elsevier Ltd on behalf of Japanese College of Cardiology.